Contents12 sections
Peptides are sold for muscle growth, fat loss, healing, sleep and anti-aging, and they are often described as having no side effects. That is not true. Any peptide strong enough to change how your body works can also cause effects you don’t want, and those effects differ a lot from one peptide to the next.
This page lists the side effects reported for the peptides people ask about most, how much human data exists for each one, and which groups of people need extra care. Many of these are research compounds that have never been properly tested in people, so “no known side effects” often means “not studied”, not “safe”.
Key Takeaways
- Peptide side effects depend on the peptide: a GLP-1 drug, a growth hormone secretagogue and a tanning peptide carry very different risks.
- Injection-site reactions, headache, nausea and flushing are the most common complaints across injectable peptides, and they are usually mild and short-lived.
- Peptides that raise growth hormone or IGF-1 can cause water retention, joint aches, tingling hands, more hunger and higher blood sugar.
- Most research peptides, including BPC-157, TB-500, MGF and KPV, have little or no human safety data, so a short list of side effects is not proof of safety.
- Approved peptides such as semaglutide, tesamorelin and PT-141 have well-documented side effects from clinical trials and should be used with medical supervision.
Side Effects of Peptides: The Full List
The table covers the most widely used peptides. The “Human data” column shows how much of the picture comes from studies in people. Where it says none or very limited, the listed effects come from user reports or from animal and cell studies, and the real risks are unknown. Each peptide name links to its compound page.
| Peptide | Reported side effects | Human data | Studies |
|---|---|---|---|
| AOD-9604 | Headache and injection-site reactions; in human trials, side effects were no more common than with placebo | Human trials | 1 |
| ARA-290 | No serious side effects reported in small trials; long-term safety unknown | Small human trials | 2 |
| BPC-157 | Injection-site reactions, nausea, dizziness and headache in user reports; it boosts blood-vessel growth in animal studies, a theoretical concern with cancer | Almost none (mainly animal studies) | – |
| Cerebrolysin | Dizziness, headache, agitation and sweating; rarely confusion or hallucinations; allergic reactions are possible because it is made from pig brain proteins | Clinical trials; approved in some countries | 3 |
| CJC-1295 | Injection-site redness, flushing and a warm feeling, headache; water retention and tingling hands from higher GH | Small human trials | – |
| DSIP | Few side effects reported; occasional headache; its effect on sleep is inconsistent across studies | Small, older human studies | 4 |
| Epitalon | Few side effects reported, but almost all human data come from one Russian research group | Very limited | 5 |
| Follistatin 344 | Injection-site reactions; it lowers FSH, so effects on fertility and reproductive hormones are a theoretical risk | None for the injected peptide | 6 |
| GHK-Cu | Skin irritation when applied; stinging, redness and small lumps when injected | Topical: small studies; injected: very limited | 7 |
| GHRP-2 | Increased hunger, water retention, tingling hands, higher cortisol and prolactin, lower insulin sensitivity | Short human studies | 8 |
| GHRP-6 | Strong hunger, water retention, tingling hands, higher cortisol and prolactin, lower insulin sensitivity | Short human studies | 8 |
| HCG | In men: higher estrogen with breast tenderness or gynecomastia, water retention, acne, headache and mood changes | Approved drug (fertility) | – |
| Hexarelin | Raises cortisol and prolactin more than most GHRPs; water retention; the GH response fades with continuous use | Short human studies | 9 |
| HGH Fragment 176-191 | Injection-site redness and swelling, headache; no proper safety trials of this exact fragment | Very limited | 10 |
| IGF-1 | Low blood sugar (the main risk), headache, fluid retention, enlarged tonsils, rarely raised pressure inside the skull; the prescription form (mecasermin) carries a tumour-growth warning | Approved drug (mecasermin) | 11 |
| IGF-1 LR3 | Low blood sugar that can last longer than with IGF-1; the same tumour-growth concern as IGF-1 | None (lab studies) | – |
| Ipamorelin | Headache, flushing, injection-site reactions, mild water retention; little effect on cortisol and prolactin compared with other GHRPs | Small human trials | – |
| KPV | Injection-site redness and itching in user reports | None (cell and animal studies) | 12 |
| LL-37 | Injection-site redness and pain; it drives inflammation and is linked to psoriasis, rosacea and lupus; it may help some cancers grow while slowing others | Very limited | 13 |
| Melanotan I | Nausea, flushing, headache, darker moles and freckles | Approved as an implant (afamelanotide) | 14 |
| Melanotan II | Nausea, flushing, spontaneous erections, loss of appetite, new or darker moles; case reports of melanoma, kidney damage and priapism | Small trials; not approved | 14 |
| MGF | Injection-site reactions; as an IGF-1 variant it may lower blood sugar | None (cell and animal studies) | 15 |
| MOTS-c | Injection-site reactions are the most common complaint; occasional nausea or stomach discomfort | Very limited | 16 |
| PEG-MGF | The same concerns as MGF, but longer-acting; injection-site reactions | None | 15 |
| PT-141 (bremelanotide) | Nausea (about 40% in trials), flushing, headache, vomiting, injection-site reactions; a brief rise in blood pressure after each dose; dark skin patches with repeated use | Approved drug (Vyleesi) | 17 |
| PTD-DBM | No human data; it activates Wnt signalling, which is also involved in some cancers, so long-term safety is unknown | None (mouse studies) | – |
| Semaglutide | Nausea, vomiting, diarrhea, constipation, stomach pain; gallbladder problems; rarely pancreatitis; a thyroid tumour warning based on rodent studies | Large trials; approved drug | 18 |
| Semax | Few reported; nasal irritation; little safety data outside Russia, where it is approved | Clinical use in Russia | – |
| Sermorelin | Injection-site pain and redness, facial flushing, headache, dizziness; rarely difficulty swallowing or hives | Formerly approved (Geref) | – |
| TB-500 | Injection-site swelling and itching, headache and tiredness in user reports; promotes blood-vessel growth, a theoretical concern with existing cancer | None for TB-500 itself | – |
| Tesamorelin | Joint and muscle pain, swollen hands and feet, injection-site redness and itching, higher blood sugar | Approved drug (Egrifta) | 19 |
| Thymosin Alpha-1 | Generally well tolerated; injection-site discomfort and redness; not for people on deliberate immune suppression, such as after a transplant | Approved in some countries (Zadaxin) | – |
| Thymosin Beta-4 | Well tolerated in small trials of eye drops, wound gel and injections; tiredness in user reports | Small human trials | – |
| Tirzepatide | Nausea, diarrhea, vomiting, constipation; can make birth control pills less reliable; a thyroid tumour warning based on rodent studies | Large trials; approved drug | – |
Often Listed With Peptides, but Not Peptides
A few compounds appear on peptide lists and vendor sites but are not peptides. Their side effects are still worth knowing:
| Compound | What it is | Side effects | Studies |
|---|---|---|---|
| Anamorelin | Oral ghrelin mimetic (small molecule); approved in Japan for cancer-related weight and muscle loss | Higher blood sugar, nausea, changes in heart conduction on an ECG | 20, 21 |
| Macimorelin | Oral ghrelin mimetic; approved as a one-time test for adult GH deficiency | Taste changes, dizziness, headache, tiredness, nausea; can prolong the QT interval | 22 |
| Pentosan polysulfate | A sulfated sugar (polysaccharide); approved as Elmiron for bladder pain | Diarrhea, nausea, hair loss, easy bruising or bleeding; long-term use is linked to retinal damage | 23 |
RU58841, a topical anti-androgen for hair loss, is another non-peptide often sold beside peptides. Our RU58841 guide covers what is known about its side effects.
Why Side Effects Differ So Much Between Peptides
No two peptides act the same way, so their side effects differ too. Semaglutide works on appetite and digestion, GHRP-6 on growth hormone and hunger, and melanotan II on skin pigment and sexual arousal. Treating them as one group makes little sense.
People differ as well. One person may use BPC-157 with no problems while another gets nausea or dizziness. Dose, body weight, health conditions, other medications and the quality of the product all change the odds.
Side Effects Most Peptides Share
Some complaints come up with almost every injectable peptide. Most are mild and pass on their own:
- Injection site reactions: redness, swelling, itching, pain or a small lump where the needle went in. These usually settle within a day or two. Spreading redness, heat, pus or a fever point to an infection and need medical care.
- Allergic reactions: rash, hives or itching are possible with any peptide. Swelling of the face, lips, tongue or throat, or trouble breathing, is a medical emergency.
- Gastrointestinal upset: nausea, vomiting, diarrhea or stomach discomfort. This is the main side effect of GLP-1 drugs, and it is also common with PT-141 and melanotan.
- Headache and flushing: common with growth hormone secretagogues, PT-141 and melanotan, and usually short-lived.
- Problems with the product itself: research peptides are not made to drug standards. Wrong doses, impurities and bacterial contamination can cause side effects that have nothing to do with the peptide. Sterile reconstitution and a third-party certificate of analysis reduce this risk but do not remove it.
These effects are usually mild. The bigger unknown for most research peptides is long-term safety, which has simply not been studied.
Peptides also fall into rough groups by purpose. Peptides in the same group are not interchangeable, but they often share side effects.
Peptides for Aging Side Effects
Peptides used for anti-aging include CJC-1295, ipamorelin, sermorelin, copper peptides (GHK-Cu), glutathione and epitalon. Human growth hormone is used this way too, but it is a prescription drug.
No peptide reverses aging. These compounds target some of its signs, such as falling growth hormone, slower skin repair or oxidative stress, and they work in very different ways. Here are the side effects to expect:
- GH-raising peptides (CJC-1295, ipamorelin, sermorelin): water retention, joint aches, tingling hands and lower insulin sensitivity
- Copper peptides: skin irritation when applied; stinging and redness when injected
- Glutathione injections: injection-site reactions and, rarely, allergic reactions
- Epitalon: few reported side effects, but very little independent human data
Peptides for Human Growth Hormone Side Effects
Growth hormone peptides include the GHRH analogues CJC-1295, sermorelin and tesamorelin, and the ghrelin mimetics ipamorelin, GHRP-2, GHRP-6 and hexarelin.
These peptides make the pituitary release more of your own growth hormone. Growth hormone itself is prescription-only, mainly for people with a proven deficiency. Their side effects follow from higher GH and IGF-1 levels:
- Lower insulin sensitivity and higher blood sugar
- Water retention and swollen hands or feet
- Joint aches and tingling or numb hands (carpal tunnel symptoms)
- More hunger with ghrelin mimetics, strongest with GHRP-6
- Higher cortisol and prolactin with GHRP-2 and hexarelin, much less with ipamorelin
- A possible cancer concern: higher IGF-1 levels are linked with some cancers in population studies, so these peptides are avoided by people with active cancer or a history of it
Peptides for Hair Growth Side Effects
Peptides for hair growth are mainly copper peptides such as GHK-Cu and AHK-Cu, applied to the scalp, and PTD-DBM.
Topical copper peptides can cause scalp itching, redness or irritation. PTD-DBM has only been tested in mice, so there is no human safety data at all. GH-raising peptides are sometimes added for hair, but they bring the GH side effects above with little evidence of a hair benefit.
Peptides for Weight Loss Side Effects
Peptides for weight loss include semaglutide, tirzepatide, tesamorelin, AOD-9604 and HGH Fragment 176-191.
They work in very different ways, and the evidence behind them is far from equal:
- GLP-1 drugs (semaglutide, tirzepatide): strong evidence for weight loss in large trials. Side effects are mostly digestive, such as nausea, vomiting, diarrhea and constipation, and are worst when the dose is raised. Less common are gallbladder problems and pancreatitis. Part of the weight lost is muscle, so protein intake and strength training matter.
- Tesamorelin: approved to reduce belly fat in people with HIV-related lipodystrophy; it can raise blood sugar and cause joint pain and swelling.
- AOD-9604 and HGH Fragment 176-191: few side effects in the data available, but AOD-9604 did not beat placebo for weight loss in human trials.
- Eating much less, whatever the cause, can bring fatigue, dizziness and constipation.
Peptide Side Effects on Women
Most peptides do not cause stronger side effects in women just because of sex. A few things do matter:
- Body weight. Women are lighter on average, so the same dose is a larger dose per kilogram. This is one reason side effects can appear at doses men tolerate.
- Peptides that act on sex hormones and sexual function. PT-141 (bremelanotide) is approved for low sexual desire in premenopausal women, kisspeptin raises the reproductive hormones LH and FSH, and follistatin lowers FSH. Any of these can affect cycles and fertility.
- Contraception and pregnancy. Tirzepatide can make birth control pills less reliable, so its label advises a non-oral or backup method for 4 weeks after starting and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Research peptides have no safety data in pregnancy or breastfeeding.
For the peptides women use most, see our guide to the best peptides for women.
Peptide Side Effects in Older Women
Older adults are more likely to have health conditions and take medications that change how a peptide affects them. For older women, the main points are:
- Kidney function declines with age. Dehydration from GLP-1 nausea, vomiting or diarrhea can cause acute kidney injury, so drinking enough fluid matters.
- Peptides that cause water retention, such as GH secretagogues and tesamorelin, are harder to tolerate with high blood pressure or heart failure.
- GLP-1 drugs cause some muscle loss alongside fat loss, which matters more when muscle and bone are already declining.
- Peptides that stimulate the immune system, such as thymosin alpha-1 and LL-37, need caution in people with autoimmune disease.
Peptide Side Effects in Older Men
The points above apply to older men as well. A few more:
- Peptides that raise testosterone, such as HCG, gonadorelin and kisspeptin, need the same checks as testosterone therapy, including prostate health and red blood cell count.
- Heart and blood pressure. PT-141 briefly raises blood pressure and should not be used with uncontrolled high blood pressure or heart disease, and macimorelin can prolong the QT interval. Heart disease is more common in older men.
- Blood sugar. Prediabetes is common later in life, and GH-raising peptides can push blood sugar higher.
Peptides Bodybuilding Side Effects
Bodybuilders often use peptides at higher doses than were ever studied, stack several at once, and combine them with HGH, insulin or anabolic steroids. That changes the risk:
- Insulin resistance. Stacking several GH-raising peptides, or adding HGH, raises blood sugar further. Over time this can lead to type 2 diabetes.
- Low blood sugar. IGF-1, IGF-1 LR3 and MGF-type peptides can lower blood sugar, and combining them with insulin can cause dangerous hypoglycemia.
- Heart strain. Long-term GH excess, as seen in acromegaly, is linked with an enlarged heart and high blood pressure. Regular blood pressure checks and bloodwork make sense.
- Fluid retention, joint pain and numb hands become more likely as GH and IGF-1 rise.
- Sport bans. WADA bans GH-releasing peptides, BPC-157 and TB-500, so tested athletes risk a ban.
Most of these problems are dose-related. The doses some bodybuilders use were never tested, so the side effects at those doses are largely unknown. For how peptides compare with anabolic steroids for muscle gain, see peptides vs steroids.
Are Peptides Safe to Use?
It depends on the peptide, and the answer is very different for approved drugs and research peptides.
Approved peptide drugs, such as semaglutide, tirzepatide, tesamorelin and bremelanotide, have been through clinical trials, and their side effects are known and listed on the label. Used as prescribed and under a doctor’s care, their risks are reasonably well understood.
Most peptides sold online, including BPC-157, TB-500, MGF, KPV and epitalon, have not been through those trials. Their safety data come mostly from animal studies, small trials and user reports. In 2023 the FDA placed BPC-157 and several other popular peptides on its list of substances that raise significant safety risks, which means US compounding pharmacies should not use them. Product quality adds more uncertainty, because research-grade peptides are not made to drug standards.
So peptides are neither automatically safe nor automatically dangerous. For the basics of how they work, see what are peptides.
Which Peptides Carry the Most Risk?
Some peptides carry clearer risks, or are unsafe for certain people:
- Melanotan II is unapproved and causes nausea, flushing and new or darker moles. There are case reports of melanoma, kidney damage and priapism in users.
- IGF-1, IGF-1 LR3 and MGF can cause low blood sugar, which is dangerous combined with insulin or fasting.
- Peptides that raise growth hormone can worsen blood sugar control in people with diabetes or prediabetes, and are avoided with active cancer.
- HCG (human chorionic gonadotropin) raises testosterone and, with it, estrogen in men, which can cause breast tenderness, gynecomastia and water retention.
- PT-141 briefly raises blood pressure, so it is not for people with uncontrolled high blood pressure or heart disease.
- GLP-1 drugs are not for people with a personal or family history of medullary thyroid cancer or MEN 2, and need care after pancreatitis.
- LL-37 and other immune-active peptides may worsen autoimmune skin conditions such as psoriasis.
A peptide can be reasonably safe for one person and unsafe for another. Health conditions and other medications matter as much as the peptide itself.
Choosing a Peptide Source
If you use research peptides despite the gaps in safety data, the product is one of the few risks you can control. Purity, sterility and the real dose vary between suppliers. Ask for a recent third-party certificate of analysis for the batch you buy, and learn how to read a peptide COA. A COA confirms identity and purity; it does not show that a product is safe to inject. Our guide to the best peptide vendors explains what else to check.
Pros
- Exceptional purity & testing (≥98%)
- Pharmaceutical-style packaging for stability
- Broad catalog across peptides & nootropics
- Strong reputation & consistency across years
Cons
- Some items frequently out of stock due to high demand
- Limited long-term data for some compounds
Are Peptides Legal?
The legal status of peptides depends on the peptide and the country. In general:
- Approved peptide drugs prescribed by a doctor or clinic, such as semaglutide or tesamorelin, are legal.
- Research peptides are sold in many countries for laboratory research only and labelled “not for human use”. Buying them to inject yourself is a legal grey area, and some countries require a prescription for many of them.
- Growth hormone is prescription-only. In the US, distributing it for anti-aging or bodybuilding is a federal crime.
- In sport, WADA bans most GH-releasing peptides, BPC-157 and TB-500.
A clinic gives you a medical professional who prescribes approved peptides and can monitor side effects. Research peptide vendors sell compounds labelled for research only, with no medical oversight.
The Bottom Line
Peptides do have side effects, and how serious they are depends on the peptide, the dose and how much is actually known about it.
- Approved peptides such as semaglutide, tesamorelin and bremelanotide have well-documented side effects, mostly nausea, injection-site reactions and, for GH-related drugs, fluid retention and higher blood sugar.
- Growth hormone peptides share a predictable set of side effects: water retention, joint aches, tingling hands, more hunger and lower insulin sensitivity.
- Most research peptides have little or no human safety data and vary in quality, so “no known side effects” usually means “not studied”. People with diabetes, heart disease, cancer or autoimmune disease need extra care.
Frequently Asked Questions
Disclaimer
Please read carefully
The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.
Not medical advice
Content here is not a substitute for professional medical advice.
Consult your doctor
Talk to your doctor before starting any supplement or new routine.
Use at your own risk
We are not responsible for adverse effects from acting on this.
Do your research
Make informed decisions about your own health.
No guarantees
Individual results vary. No claims about outcomes.
Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.



